A quiet world first for St. Paul’s

Jul 10, 2017 | Spotlight | News

In the Pathology Lab at St. Paul’s, our breakthrough research team gathers at the new mass spectrometry machineIn the Pathology Lab at St. Paul’s, our breakthrough research team gathers at the new mass spectrometry machine

St. Paul’s medical biochemists make breakthrough advance on mysterious disease.

Only in this century has the disease known as IgG4-RD begun to gain prominence. Its origins are still being defined, although research suggests it may be an autoimmune or allergic disorder. Left untreated, it can cause organ failure. It affects one in 200 people, which sounds rare—but that’s 35 million people.

Even its name, IgG4-RD, does little to promote public awareness.

Fortunately, Dr. Andre Mattman, a medical biochemist with the Department of Pathology and Laboratory Medicine at St. Paul’s, is very aware of IgG4-RD. So aware that earlier this year a breakthrough by Dr. Mattman and his colleagues changed the way this disease is diagnosed and treated.

Click here to read more 

Related Articles

Add new comment